Showing 19,861 - 19,880 results of 99,506 for search '(( 5 wt decrease ) OR ( 5 ((non decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.68s Refine Results
  1. 19861
  2. 19862
  3. 19863
  4. 19864
  5. 19865

    Criterion validity of the C-IVI questionnaire. by Wei Pan (701)

    Published 2025
    “…Of these, 15.8% presented MMD, 79.4%, 13.5%, 7.0%, and 0.2% had no, mild, moderate, and severe VI, respectively. …”
  6. 19866
  7. 19867
  8. 19868
  9. 19869
  10. 19870
  11. 19871
  12. 19872
  13. 19873
  14. 19874

    Table2_The impact of sport-specific physical fitness change patterns on lower limb non-contact injury risk in youth female basketball players: a pilot study based on field testing... by Yuanqi Huang (7301531)

    Published 2023
    “…The 3/4 basketball court sprint performance improved, while urinary protein and RPE levels decreased after the speed test.</p><p>Conclusion: The sport-specific physical fitness change pattern can impact the lower limb non-contact injury risk of young female basketball players in Fujian Province, specifically in terms of agility and speed. …”
  15. 19875

    Table1_The impact of sport-specific physical fitness change patterns on lower limb non-contact injury risk in youth female basketball players: a pilot study based on field testing... by Yuanqi Huang (7301531)

    Published 2023
    “…The 3/4 basketball court sprint performance improved, while urinary protein and RPE levels decreased after the speed test.</p><p>Conclusion: The sport-specific physical fitness change pattern can impact the lower limb non-contact injury risk of young female basketball players in Fujian Province, specifically in terms of agility and speed. …”
  16. 19876
  17. 19877

    Basal PLD activity is strongly stimulated by the D1/5R agonist and blocked by the D1/5R, mGluR5, mGluR1, and the PLD-linked mGluR antagonists in the amygdala of cocaine CPP animals... by Balaji Krishnan (203728)

    Published 2011
    “…A similar reduction in PEtOH levels was observed with application of either the PLD-linked mGluR antagonist, PCCG-13 (62.9±10.6, n = 7, <sup>##</sup><i>p</i><0.01) or the mGluR1 antagonist, LY367385 (75.0±13.9, n = 12, <sup>##</sup><i>p</i><0.01), while the mGluR5 antagonist, MPEP, did not decrease basal PLD activity (305.7±31.5, n = 7, ns) within the cocaine CPP group but were significantly increased compared to (*<i>p</i><0.05) the saline treated group. …”
  18. 19878
  19. 19879
  20. 19880